Enrichment of type 1 innate lymphoid cells in the course of human atherosclerotic plaque development suggests contribution to atherogenesis

IntroductionInnate lymphoid cells (ILCs) have been implicated in multiple pathologic conditions, including atherogenesis, as documented in experimental mice studies, however, their role in atherosclerosis in humans remains unexplored.MethodsHere, we identify ILCs and their dynamics in early, advance...

Full description

Bibliographic Details
Main Authors: Kartika R. Pertiwi, Marcel B. M. Teunissen, Gabrielle Krebbers, Martine C.M. Willems, Laurens Huisman, Cindy Poelen, Allard C. van der Wal, Onno J. de Boer
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-04-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2024.1354617/full
_version_ 1827294178376155136
author Kartika R. Pertiwi
Kartika R. Pertiwi
Marcel B. M. Teunissen
Gabrielle Krebbers
Martine C.M. Willems
Martine C.M. Willems
Laurens Huisman
Laurens Huisman
Cindy Poelen
Allard C. van der Wal
Onno J. de Boer
author_facet Kartika R. Pertiwi
Kartika R. Pertiwi
Marcel B. M. Teunissen
Gabrielle Krebbers
Martine C.M. Willems
Martine C.M. Willems
Laurens Huisman
Laurens Huisman
Cindy Poelen
Allard C. van der Wal
Onno J. de Boer
author_sort Kartika R. Pertiwi
collection DOAJ
description IntroductionInnate lymphoid cells (ILCs) have been implicated in multiple pathologic conditions, including atherogenesis, as documented in experimental mice studies, however, their role in atherosclerosis in humans remains unexplored.MethodsHere, we identify ILCs and their dynamics in early, advanced, and complicated human carotid- and aortic atherosclerotic plaques, using a multiplex immunohistochemical quadruple-staining technique with prototypic transcription factors T-bet, GATA3, or RORgt for identification of the ILC1, ILC2 and ILC3 subsets, respectively, in combination with lineage markers CD3, CD20/ CD79a and CD56 to exclude other lymphoid cell types. ILC subsets were quantified, and to put this in perspective, their numbers were expressed as percentage of the total number of infiltrated lymphoid cells and related to the frequency of conventional T cells, B cells, NK cells, and NKT cells. ResultsAll ILC subsets were present in every different stage of atherogenesis. ILC1s were the most abundant ILC subset, and their numbers significantly increased in the course of plaque development, but paradoxically, their relative frequency was reduced because of a higher increment of T cells and B cells. The numbers of ILC2s and ILC3s also gradually increased, but this trend did not achieve significance. T cell subsets always significantly outnumbered their ILC counterparts, except for the early lesions where the proportion of ILC1s was markedly higher, albeit not significant. DiscussionThe high abundance of ILC1s in the early stages and further significant enrichment in later stages, suggest they may participate in the initiation and development of atherogenesis, and thus, may represent a novel target to prevent or treat atherosclerosis.
first_indexed 2024-04-24T13:52:25Z
format Article
id doaj.art-4d9ca244153d4cf8b8cbf3794bc01946
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-04-24T13:52:25Z
publishDate 2024-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-4d9ca244153d4cf8b8cbf3794bc019462024-04-04T04:26:39ZengFrontiers Media S.A.Frontiers in Immunology1664-32242024-04-011510.3389/fimmu.2024.13546171354617Enrichment of type 1 innate lymphoid cells in the course of human atherosclerotic plaque development suggests contribution to atherogenesisKartika R. Pertiwi0Kartika R. Pertiwi1Marcel B. M. Teunissen2Gabrielle Krebbers3Martine C.M. Willems4Martine C.M. Willems5Laurens Huisman6Laurens Huisman7Cindy Poelen8Allard C. van der Wal9Onno J. de Boer10Department of Pathology, Amsterdam University Medical Centers, location Academic Medical Center, University of Amsterdam, Amsterdam, NetherlandsFaculty of Medicine and Department of Biology Education, Faculty of Mathematics and Natural Science, Universitas Negeri Yogyakarta, Yogyakarta, IndonesiaDepartment of Dermatology, Amsterdam University Medical Centers, location Academic Medical Center, University of Amsterdam, Amsterdam, NetherlandsDepartment of Dermatology, Amsterdam University Medical Centers, location Academic Medical Center, University of Amsterdam, Amsterdam, NetherlandsDepartment of Vascular Surgery, Amsterdam University Medical Centers, location Academic Medical Center, University of Amsterdam, Amsterdam, NetherlandsDepartment of Vascular Surgery, Flevoziekenhuis, Almere, NetherlandsDepartment of Vascular Surgery, Amsterdam University Medical Centers, location Academic Medical Center, University of Amsterdam, Amsterdam, NetherlandsDepartment of Vascular Surgery, Flevoziekenhuis, Almere, NetherlandsDepartment of Pathology, Amsterdam University Medical Centers, location Academic Medical Center, University of Amsterdam, Amsterdam, NetherlandsDepartment of Pathology, Amsterdam University Medical Centers, location Academic Medical Center, University of Amsterdam, Amsterdam, NetherlandsDepartment of Pathology, Amsterdam University Medical Centers, location Academic Medical Center, University of Amsterdam, Amsterdam, NetherlandsIntroductionInnate lymphoid cells (ILCs) have been implicated in multiple pathologic conditions, including atherogenesis, as documented in experimental mice studies, however, their role in atherosclerosis in humans remains unexplored.MethodsHere, we identify ILCs and their dynamics in early, advanced, and complicated human carotid- and aortic atherosclerotic plaques, using a multiplex immunohistochemical quadruple-staining technique with prototypic transcription factors T-bet, GATA3, or RORgt for identification of the ILC1, ILC2 and ILC3 subsets, respectively, in combination with lineage markers CD3, CD20/ CD79a and CD56 to exclude other lymphoid cell types. ILC subsets were quantified, and to put this in perspective, their numbers were expressed as percentage of the total number of infiltrated lymphoid cells and related to the frequency of conventional T cells, B cells, NK cells, and NKT cells. ResultsAll ILC subsets were present in every different stage of atherogenesis. ILC1s were the most abundant ILC subset, and their numbers significantly increased in the course of plaque development, but paradoxically, their relative frequency was reduced because of a higher increment of T cells and B cells. The numbers of ILC2s and ILC3s also gradually increased, but this trend did not achieve significance. T cell subsets always significantly outnumbered their ILC counterparts, except for the early lesions where the proportion of ILC1s was markedly higher, albeit not significant. DiscussionThe high abundance of ILC1s in the early stages and further significant enrichment in later stages, suggest they may participate in the initiation and development of atherogenesis, and thus, may represent a novel target to prevent or treat atherosclerosis. https://www.frontiersin.org/articles/10.3389/fimmu.2024.1354617/fullinnate lymphoid cellsatherosclerosisinnate immunityinflammationlymphocytesimmunohistochemistry
spellingShingle Kartika R. Pertiwi
Kartika R. Pertiwi
Marcel B. M. Teunissen
Gabrielle Krebbers
Martine C.M. Willems
Martine C.M. Willems
Laurens Huisman
Laurens Huisman
Cindy Poelen
Allard C. van der Wal
Onno J. de Boer
Enrichment of type 1 innate lymphoid cells in the course of human atherosclerotic plaque development suggests contribution to atherogenesis
Frontiers in Immunology
innate lymphoid cells
atherosclerosis
innate immunity
inflammation
lymphocytes
immunohistochemistry
title Enrichment of type 1 innate lymphoid cells in the course of human atherosclerotic plaque development suggests contribution to atherogenesis
title_full Enrichment of type 1 innate lymphoid cells in the course of human atherosclerotic plaque development suggests contribution to atherogenesis
title_fullStr Enrichment of type 1 innate lymphoid cells in the course of human atherosclerotic plaque development suggests contribution to atherogenesis
title_full_unstemmed Enrichment of type 1 innate lymphoid cells in the course of human atherosclerotic plaque development suggests contribution to atherogenesis
title_short Enrichment of type 1 innate lymphoid cells in the course of human atherosclerotic plaque development suggests contribution to atherogenesis
title_sort enrichment of type 1 innate lymphoid cells in the course of human atherosclerotic plaque development suggests contribution to atherogenesis
topic innate lymphoid cells
atherosclerosis
innate immunity
inflammation
lymphocytes
immunohistochemistry
url https://www.frontiersin.org/articles/10.3389/fimmu.2024.1354617/full
work_keys_str_mv AT kartikarpertiwi enrichmentoftype1innatelymphoidcellsinthecourseofhumanatheroscleroticplaquedevelopmentsuggestscontributiontoatherogenesis
AT kartikarpertiwi enrichmentoftype1innatelymphoidcellsinthecourseofhumanatheroscleroticplaquedevelopmentsuggestscontributiontoatherogenesis
AT marcelbmteunissen enrichmentoftype1innatelymphoidcellsinthecourseofhumanatheroscleroticplaquedevelopmentsuggestscontributiontoatherogenesis
AT gabriellekrebbers enrichmentoftype1innatelymphoidcellsinthecourseofhumanatheroscleroticplaquedevelopmentsuggestscontributiontoatherogenesis
AT martinecmwillems enrichmentoftype1innatelymphoidcellsinthecourseofhumanatheroscleroticplaquedevelopmentsuggestscontributiontoatherogenesis
AT martinecmwillems enrichmentoftype1innatelymphoidcellsinthecourseofhumanatheroscleroticplaquedevelopmentsuggestscontributiontoatherogenesis
AT laurenshuisman enrichmentoftype1innatelymphoidcellsinthecourseofhumanatheroscleroticplaquedevelopmentsuggestscontributiontoatherogenesis
AT laurenshuisman enrichmentoftype1innatelymphoidcellsinthecourseofhumanatheroscleroticplaquedevelopmentsuggestscontributiontoatherogenesis
AT cindypoelen enrichmentoftype1innatelymphoidcellsinthecourseofhumanatheroscleroticplaquedevelopmentsuggestscontributiontoatherogenesis
AT allardcvanderwal enrichmentoftype1innatelymphoidcellsinthecourseofhumanatheroscleroticplaquedevelopmentsuggestscontributiontoatherogenesis
AT onnojdeboer enrichmentoftype1innatelymphoidcellsinthecourseofhumanatheroscleroticplaquedevelopmentsuggestscontributiontoatherogenesis